DEPLOYDatabase

Company

Warp Sciences

Warp Sciences builds AI-driven robotic chemistry labs in the US that make and test drug-discovery compounds for pharma and biotech customers, starting with…

Status
active

The verified answer

As of Oct 2026, DEPLOY verifies Warp Sciences: $215.0M raised. 4 sources back the record.

Deploy Watch

Track Warp Sciences on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Key facts

Series A valuation (reported, Oct 2026)

TechCrunch reports the $215M Series A values Warp Sciences at $865 million, per co-founder Kevin Weil.

Business model (company-stated, Oct 2026)

US preclinical chemistry CRO that makes and tests molecules for pharma and biotech customers, automating lab work with robots over time. Does not develop its own drugs.

Data & sources

News coverage

1

Web sources

3

4 sources backing this record.View all →

Warp Sciences on the deployment map

View the global map

Warp Sciences has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

No verified deployments for Warp Sciences on the DEPLOY record yet. Track Warp Sciences to know the moment the first one is verified.

Relationships

Current leadership (4)

Founders (4)

See all founders across the registry →

Safety record

No incidents on record for Warp Sciences.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Mentioned on (5)

Registry pages whose text names Warp Sciences.